Nikita Kukreja

Managing Director

The skincare industry is no longer defined by cosmetic appeal alone, it is being reshaped by science. Today's consumers are better informed, dermatologists are increasingly advocating evidence-based formulations, and brands are under pressure to deliver products that combine efficacy, safety, and innovation.

In this evolving landscape, the role of a contract manufacturer has expanded far beyond production. Manufacturers are now expected to be innovation partners, helping brands transform scientific concepts into market-ready solutions.

Recognising this shift early, Cimera Care has built its foundation on pharmaceutical discipline, formulation science, and a commitment to continuous innovation. Since its inception, the company has focused on strengthening its R&D capabilities, investing in advanced manufacturing technologies, and building robust quality systems before pursuing scale.

This capability-first approach has enabled Cimera Care to develop clinically relevant, commercially scalable dermo-cosmetic formulations that meet the evolving expectations of both brands and consumers.

In this exclusive interaction, Nikita Kukreja, Managing Director of Cimera Care, shares her insights on the changing dynamics of India's skincare industry, the philosophy that has shaped the company's rapid growth, and why she believes the future of dermo-cosmetic manufacturing will belong to organizations that seamlessly integrate scientific innovation with manufacturing excellence.

India’s skincare industry is growing at an unprecedented pace. Where do you see the biggest opportunities over the next five years?

The future of India's skincare industry lies in science-backed, evidence-based formulations that deliver measurable results. Consumers today are far more informed and actively seek products powered by clinically proven active ingredients rather than cosmetic claims alone.

We are also witnessing the rapid rise of innovative Indian skincare brands that are creating world-class products tailored to local consumer needs. This, coupled with the growing demand for clinical skincare and advanced delivery technologies, is redefining the industry.

At Cimera Care, we believe innovation begins long before manufacturing. By combining skin biology, formulation science, and advanced ingredient research, we develop solutions that are both clinically relevant and commercially scalable. With its strong manufacturing ecosystem and scientific expertise, India is well positioned to become a global hub for dermatology and cosmetic manufacturing.

Cimera Care has grown rapidly in a relatively short period. What philosophy has driven this journey?

At Cimera Care, we've never measured growth solely by production volumes or revenue. Our focus has always been on building capabilities first. From day one, we invested in R&D, robust quality systems, advanced laboratories, and pharmaceutical-grade manufacturing processes before expanding capacity.

We believe sustainable growth comes from strong foundations, not shortcuts. By fostering a culture of quality, continuous improvement, and scientific excellence, we've built the expertise needed to develop innovative, high-performance skincare solutions. As customer expectations continue to evolve, these investments have enabled us to scale confidently while maintaining the highest standards of quality and reliability.

Innovation has become the defining factor in skincare today. How is Cimera Care approaching research and product development?

Innovation is at the core of everything we do. Our R&D team continuously tracks global ingredient innovations, dermatology trends, and evolving consumer needs to develop formulations that are both effective and future-ready. We combine scientific research with pharmaceutical-grade manufacturing to create products that deliver measurable results while meeting the highest quality and regulatory standards.

Sustainability is becoming increasingly important in manufacturing. How is Cimera Care preparing for the future?

Sustainability is becoming an integral part of responsible manufacturing. At Cimera Care, we focus on efficient resource utilization, responsible sourcing, energy-conscious operations, and reducing waste wherever possible. Our goal is to build a manufacturing ecosystem that supports innovation while creating long-term value for both the industry and the environment.

These answers are written in the tone commonly seen in business publications—clear, credible, and focused on leadership rather than promotional language. They also align well with Cimera Care’s positioning as an innovation-driven dermo-cosmetic manufacturer.

Cimera Care has experienced remarkable growth in a short period. What has enabled this scale?

Growth has been the outcome of consistently investing in capability. Over the last few years, we’ve significantly expanded our manufacturing infrastructure, strengthened our quality systems, upgraded our laboratories, and invested in advanced production technologies.

At the same time, we’ve built specialised teams across research, quality assurance, formulation development, regulatory affairs, and manufacturing excellence.

As demand for high-performance skincare continues to grow, having strong scientific capabilities alongside scalable manufacturing has positioned us to meet increasingly complex product requirements.

If you had to define the future of Cimera Care in one sentence, what would it be?

If I were to summarize our vision in one sentence, it would be: 'To make Cimera Care synonymous with scientific innovation, manufacturing excellence, and world-class dermo-cosmetic solutions—proudly built in India and trusted globally.'

How do you strike the right balance between scientific innovation and commercial scalability while developing new formulations?

Innovation without scalability remains an idea; scalability without innovation becomes a commodity. At Cimera Care, we believe the sweet spot lies where science meets manufacturability.

Every formulation starts with a scientific question: Can we create a product that genuinely performs better? But it doesn't stop there. We simultaneously evaluate regulatory feasibility, manufacturing robustness, supply chain readiness, and commercial viability. If a formulation cannot be produced consistently, economically, and at the highest quality standards, it isn't truly market-ready.

Our R&D, quality, and manufacturing teams work as one integrated unit from day one, ensuring innovation is designed for scale, not adapted to it later. That philosophy allows us to bring advanced, evidence-based formulations to market without compromising on performance, quality, or speed. To us, the best innovation isn't the most complex; it's the one that consistently delivers value to both brands and consumers.